- No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
6785
TWO
Week ended 14 Aug 2026
Weekly Investor Report
Alar Pharmaceuticals Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
Latest close
100.0 TWD
1.4%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -37.6% below the Trend Line and sits at 3.6% of its 52-week range. The latest completed week returned 1.4%, after a -8.3% four-week move. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.
Setup score
20
out of 100
Latest Close
100.0 TWD
14 Aug 2026
1W Return
1.4%
latest completed week
4W Return
-8.3%
short-term follow-through
12W Return
-22.2%
quarterly tape
Trend Breadth
53.8%
28 of 52 weeks active
Volume Ratio
0.5x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
1.4%
Latest completed week; four-week move -8.3%.
Indicator stack
30/46
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 34.49%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
0 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -37.6% below the Trend Line and sits at 3.6% of its 52-week range. The latest completed week returned 1.4%, after a -8.3% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.5x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
14 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0112-week average 0.00
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.01Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -8.3% over four weeks, -22.2% over 12 weeks, and -44.4% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year28
Trend breadth53.8%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.31Latest activity-pressure read.
Pressure change13.7%Four-week change in activity pressure.
Leadership-66.52Latest relative-leadership reading.
RS change-6.0%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 0 relevant articles.
0 positive · 0 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-68.5%Distance below the 52-week high.
13-week volatility5.4%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
20 Mar
17 Apr
15 May
12 Jun
10 Jul
14 Aug
Weeks higher7 of 2619 weeks finished lower.
Best week+8.8%Week of 3 Jul.
Worst week-17.6%Week of 27 Feb.
Latest week+1.4%Week of 14 Aug.
Shape of recent returns
Strong gains2
Modest gains5
Flat weeks0
Modest losses7
Sharp losses12
Recent vol5.4%13-week weekly-return volatility.
Base vol8.1%52-week weekly-return volatility.
Up/down split22/30Count of positive and negative weeks in the 52-week window.
Average skew5.7% / -5.6%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorTW Healthcare
4-week rank87 / 100
Group average0.1%
Trend breadth34.0%
Trend34.0%active weekly trend signals
MD60.0%positive activity pressure
RS9.0%positive relative leadership
Four-week leaders
IndustryTW Drug Manufacturers - Specialty & Generic
4-week rank36 / 42
Group average-0.1%
Trend breadth21.4%
Trend21.4%active weekly trend signals
MD45.2%positive activity pressure
RS4.8%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape22/100
Trend, activity pressure, participation, and risk combine to a 22/100 tape read.
Indicator analysis9/100Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.
Activity pressure 0.01; No reversal markers Next-Week ExpectancyNegative 34.49%Next-week expectancy is negative with a 34.49% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 0 relevant articles.
Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 14 Aug 2026 | 100.0 TWD | 1.4% | 160.4 TWD | 198.2 TWD | -0.31 | -66.52 | 220.1K | Off |
| 7 Aug 2026 | 98.60 TWD | 4.6% | 166.4 TWD | 198.4 TWD | -0.35 | -66.33 | 198.2K | Off |
| 31 Jul 2026 | 94.30 TWD | -13.1% | 173.4 TWD | 198.7 TWD | -0.24 | -67.36 | 568.0K | Off |
| 24 Jul 2026 | 108.5 TWD | -0.5% | 180.5 TWD | 198.9 TWD | -0.25 | -63.37 | 218.2K | Off |
| 17 Jul 2026 | 109.0 TWD | -6.8% | 186.5 TWD | 199.1 TWD | -0.36 | -62.77 | 460.1K | Off |
| 10 Jul 2026 | 117.0 TWD | -5.3% | 192.2 TWD | 199.5 TWD | -0.51 | -62.80 | 766.0K | Off |
| 3 Jul 2026 | 123.5 TWD | 8.8% | 197.7 TWD | 199.8 TWD | -0.86 | -62.31 | 356.0K | Off |
| 26 Jun 2026 | 113.5 TWD | -6.2% | 202.2 TWD | 200.1 TWD | -1.18 | -63.99 | 446.1K | Off |
| 19 Jun 2026 | 121.0 TWD | 2.1% | 205.8 TWD | 200.4 TWD | -1.42 | -63.57 | 315.0K | Off |
| 12 Jun 2026 | 118.5 TWD | -0.8% | 210.2 TWD | 200.7 TWD | -1.59 | -62.84 | 514.0K | Off |
| 5 Jun 2026 | 119.5 TWD | -2.8% | 215.6 TWD | 201.1 TWD | -1.68 | -63.69 | 659.5K | Off |
| 29 May 2026 | 123.0 TWD | -4.3% | 220.4 TWD | 201.5 TWD | -1.67 | -62.77 | 445.0K | Off |
| 22 May 2026 | 128.5 TWD | 1.2% | 225.4 TWD | 201.8 TWD | -1.66 | -59.23 | 594.5K | Off |
| 15 May 2026 | 127.0 TWD | -7.3% | 230.6 TWD | 202.1 TWD | -1.61 | -58.98 | 589.3K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.